Close Menu

NEW YORK (GenomeWeb) – Sphere Fluidics announced today that it has closed an additional tranche of $2.9 million in a funding round, securing a total of$4.8 million.

According to Sphere, it will use the funding for working capital for the Cyto-Mine single-cell analysis system, expansion of the UK facility, and to open a new US sales office and demo lab in California, thereby doubling the company's workforce. The Cyto-Mine system automates single-cell screening, sorting, imaging, and dispensing to speed biopharmaceutical discovery.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.